Daklinza is an antiviral medicine that contains Daclatasvir as an active substance, which helps fight the virus that causes hepatitis C.Daklinza is produced by Bristol-Myers Squibb Pharma Laboratories and can be purchased from conventional pharmacies as oral tablets.
Daklinza Indications
Daklinza is indicated for the treatment of hepatitis C in adults.
Daklinza’s mode of use
Daklinza is intended for use by taking 1 tablet of 60mg per day for 14 to 24 weeks, as directed by your doctor.
Daklinza Side Effects
The most common side effects of Daklinza include headache, nausea, tiredness, loss of appetite, difficulty sleeping, dizziness, migraine, shortness of breath, heartburn, skin changes and diarrhea.
Daklinza Contraindications
Daklinza is contraindicated for people who are allergic to any substance of the formula, as well as for patients taking Phenytoin, Carbamazepine, Oxcarbazepine, Phenobarbital, Rifampicin, Rifabutin, Rifapentin, Dexamethasone or its composition.
